Experts advising the World Health Organization on pandemic influenza and writing some of its guidance did not disclose their financial ties to the pharmaceutical industry, according to an investigative report in the BMJ.
The 2009 pandemic of H1N1 influenza led people
around the globe to create narratives about the epidemic defined by the question of trust; these narratives ranged from true conspiracy theories to simply accounts in which mistrust and betrayal formed…
The development of a vaccine is typically a long process involving an intensive research and development stage, animal testing, clinical trials and regulation, and mass production. Given this long timeline, how is a country able to respond to a…
This article deals with the status and efforts regarding the 2009 flu pandemic by country and continent/region. As the pandemic progressed, laboratory testing and confirmation decreased. Confirmed figures for the United Kingdom, in particular, are…
The 2009 flu pandemic in Asia, part of an epidemic in 2009 of a new strain of influenza A virus subtype H1N1 causing what has been commonly called swine flu, afflicted at least 394,133 people in Asia with 2,137 confirmed deaths: there were 1,035…
The 2009 flu pandemic in Europe was part of a pandemic involving a new strain of influenza, subtype H1N1. H1N1 is commonly called swine flu. The pandemic infected at least 125,550 people in Europe. There were 458 confirmed deaths in Turkey, 438…
Harvey V. Fineberg, M.D., Ph.D., discusses lessons learned from the global response to the 2009 H1N1 pandemic, identifying some of the key successes and shortcomings in the global response, on the basis of the findings and conclusions of an…
This paper discusses lessons learned from response to the 2009 H1N1 pandemic in Asia . Asia is considered a hot spot for the emergence of new pathogens including past influenza pandemics. This discrepancy between what was planned for and what emerged…